Background/Aims: Consumption of a high-fat (HF) diet exacerbates metabolic cardiomyopathy through lipotoxic mechanisms. In this study, we explored the role of aldehyde dehydrogenase-2 (ALDH2) in myocardial damage induced by a HF diet. Methods: Wild-type C57 BL/6J mice were fed a HF diet or control diet for 16 weeks. ALDH2 overexpression was achieved by injecting a lentiviral ALDH2 expression vector into the left ventricle. Results: Consumption of a HF diet induced metabolic syndrome and myocardial remodeling, and these deleterious effects were attenuated by ALDH2 overexpression. In addition, ALDH2 overexpression attenuated the cellular apoptosis and insulin resistance associated with a HF diet. Mechanistically, ALDH2 overexpression inhibited the expression of c-Jun N-terminal kinase (JNK)-1, activated protein 1 (AP-1), insulin receptor substrate 1 (IRS-1), 4-hydroxynonenal, caspase 3, transforming growth factor β1, and collagen I and III, and enhanced Akt phosphorylation. Conclusion: ALDH2 may effectively attenuate myocardial remodeling and contractile defects induced by a HF diet through the regulation of the JNK/AP-1 and IRS-1/Akt signaling pathways. Our study demonstrates that ALDH2 plays an essential role in protecting cardiac function from lipotoxic cardiomyopathy.
Introduction
Chronic consumption of a high-fat (HF) diet leads to metabolic syndrome (MS), which is characterized by a number of metabolic disorders, including obesity, impaired glucose tolerance, and high triglyceride levels [1] . Obesity induced by a HF diet is associated with the increased generation of reactive oxygen species (ROS), which induce oxidative stress in the body [2] . The oxidative stress induced by obesity causes cardiovascular complications, including lipotoxic cardiomyopathy, which can manifest as myocardial remodeling and cardiac dysfunction [3] . Previous studies have shown that glucose/lipid metabolism disorder and hypertension contribute to changes in left ventricular structure and function [4] [5] [6] .
Mitochondrial aldehyde dehydrogenase type 2 (ALDH2) is a key enzyme involved in cardiac protection [7] . ALDH2 activation correlates strongly with cardioprotective effects in a number of model systems [8] [9] [10] . ALDH2 is activated by several pathways, including the c-Jun N-terminal kinase (JNK)/activated protein-1 (AP-1) pathway, which plays an important role in cardiac remodeling and cellular apoptosis [11, 12] . JNK regulates the activity of numerous mitochondrial and nuclear proteins by phosphorylation [13] . In particular, the JNK/AP-1 signaling pathway may facilitate the insulin resistance and myocardial hypertrophy induced by oxidative stress [14, 15] . Furthermore, insulin receptor substrate 1 (IRS-1) and serinethreonine protein kinase Akt regulate the insulin resistance and cell apoptosis associated with oxidative stress [16, 17] . ALDH2 protects against cardiac abnormalities in HF diet induced obesity through a mechanism related to autophagy regulation and SUV39H-Sirt1-dependent PGC-1α deacetylation [18] . However, it remains unclear whether ALDH2 regulates the JNK/ AP-1 or IRS-1/Akt signaling pathways during myocardial remodeling induced by MS.
In this study, we investigated the protective role of ALDH2 in lipotoxic cardiomyopathy induced by MS, and we explored the underlying signaling mechanism. We produced a mouse model of MS; we overexpressed ALDH2 in this model to determine whether ALDH2 inhibits oxidative stress and insulin resistance and protects against cardiac dysfunction and myocardial tissue damage induced by a HF diet. In addition, we explored the mechanisms of cardioprotection associated with ALDH2 overexpression, with particular focus on the JNK/ AP-1 and IRS-1/Akt signaling pathways.
Materials and Methods

Experimental animals
All animal care and experimental protocols complied with the guidelines for the care and use of laboratory animals of Shandong University. The mice were housed in a temperature-controlled environment with a 12-h light, 12-h dark cycle, and had access to water and food ad libitum. The mice in the control group (NC group) were fed standard chow and tap water, while the mice in the experimental group were fed a HF diet. After 16 weeks, the mice were evaluated for MS using criteria analogous to those of Adult Treatment Panel III. A diagnosis of MS was indicated by the presence of ≥3 of the following pathological features: high fasting glucose, hypertriglyceridemia, low high-density lipoprotein-cholesterol (HDL-C), excessive waist circumference, or hypertension. A total of 43 mice were found to exhibit symptoms of MS and were divided into three groups: the MS group (n=15), which continued to be fed a HF diet and received the injection of normal saline into the left ventricle; the green fluorescent protein (GFP) vector control group (n=14), which continued to be fed a HF-diet and received an injection of the GFP lentiviral control vector into the left ventricle; and the ALDH2 group (n=14), which continued to be fed a HF-diet and received an injection of the ALDH2 lentiviral vector into the left ventricle. The mice were anesthetized with 1% isoflurane prior to injection. To inject into the left ventricle, the heart was exteriorized by anterior thoracotomy. A 25-μL volume of lentivirus solution or normal saline was injected quickly into three different locations in the left ventricle using a 1-ml syringe. After the injection, the pneumothorax was evacuated and the chest was closed.
Cellular Physiology and Biochemistry
Bodyweight measurement and serologic examination On a monthly basis, venous blood was collected after overnight fasting. Fasting concentrations of serum cholesterol, triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), HDL-C, fasting blood glucose (FBG), and fasting insulin (FINS) were evaluated at the Department Clinical Laboratory (Qilu Hospital affiliated with Shandong University, Jinan, China). The insulin resistance index (IRI) was calculated according to the following formula: IRI= (FBG × FINS)/22.5, as described previously [19] .
Echocardiographic assessment
To examine cardiac structure and function, mice were anesthetized by 1% isoflurane and evaluated using two-dimensional guided M-mode echocardiography on a Vevo 770 instrument equipped with a 30 MHz transducer (RMV 707B; Visual Sonics, Toronto, Canada). Left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), interventricular septal thickness (IVSd) and left ventricular posterior wall thickness at end diastole (LVPWd) were recorded from the M-mode images. Ejection fraction (EF) and fractional shortening (FS) were calculated as follows: EF = (LVEDV−LVESV)/LVEDV×l00%; FS = (LVEDD−LVESD)/LVEDD×l00%, as described previously [20] . All echocardiograms were performed by one experienced individual using a hand-held probe. Parameters were measured over five consecutive cycles.
Histological examination
Following anesthesia and euthanasia, a portion of the left ventricle was excised, rinsed with phosphatebuffered saline (PBS), and fixed immediately in 10% neutral-buffered formalin. The specimens were embedded in paraffin, cut into 5-μm sections, and stained with hematoxylin and eosin (HE) and Masson's trichrome (Sigma-Aldrich, St. Louis, MO). The percentage of Masson blue staining was measured in 10 randomly selected fields on each section of three non-consecutive serial sections from each mouse. The remaining heart tissue was frozen at -80°C for western blotting and detection of ALDH2 enzymatic activity.
Transmission electron microscopy
A portion of the myocardium of approximately 2.5 mm 3 was fixed with 2.0% glutaraldehyde for examination by electron microscopy. The sections were examined on an H-7000FA transmission electron microscope (Hitachi Co. Ltd., Tokyo, Japan).
Measurement of mitochondrial ALDH2 activity
Mitochondrial ALDH2 activity was measured at room temperature in a buffer containing 33 mM sodium pyrophosphate, 0.8 mM NAD + , 15 mM propionaldehyde, and 50 μg protein. The substrate of ALDH2 was oxidized to acetic acid, while NAD + was reduced to NADH. NADH production was determined by measuring absorbance at 340 nm. ALDH2 activity was expressed as nmol NADH produced per min per mg protein.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay
Sections of ventricular tissue (5 μm thick) were paraffin-embedded and incubated in a proteinase K solution for 30 min. The sections were then stained with a terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) kit (Roche, Basel, Switzerland) following the manufacturer's protocols. Nuclei were identified by DAPI staining. TUNEL-positive cells were counted using a fluorescence microscope (Olympus, Tokyo, Japan) at 400× magnification, and the percentage of apoptotic cells was calculated.
Measurement of mitochondrial membrane potential
Changes in mitochondrial membrane potential (ΔΨm) were determined using the JC-1 fluorescent probe (Life Technologies, Carlsbad, CA). Purified mitochondria were stained with JC-1 at 37°C for 20 min and analyzed by flow cytometry (FACSCalibur; BD, Franklin Lakes, NJ) or by confocal microscopy. Fluorescence emission was measured at 530 nm for the monomer form of JC-1 (green), and at 590 nm for JC-1 aggregates (red). A reduction in ΔΨm is indicated by a decrease in fluorescence at 590 nm. 
Measurement of ROS
Dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence (Life Technologies) was used to measure intracellular ROS. Cardiomyocytes were incubated with 5 mM DCFH-DA for 20 min at 37°C in Hank's balanced salt solution, rinsed with PBS, recovered in complete Dulbecco's modified Eagle's medium, and analyzed immediately with a laser-scanning confocal microscope (Model LSM710; Zeiss, Jena, Germany). Fluorescence intensity was measured using Image-Pro Plus software (Media Cybernetics, Atlanta, GA).
Immunohistochemical staining
After the sections were dewaxed and rehydrated, antigen retrieval was performed for 15 min in 1% citric acid buffer (pH 6.0) at 92-98°C. The slides were cooled at room temperature for 30 min, rinsed with PBS, and incubated for 20 min with 5% bovine serum albumen to block nonspecific binding. The slides were incubated with an anti-4-hydroxynonenal (4-HNE) antibody (1:200; rabbit polyclonal anti-mouse; SigmaAldrich) overnight at 4°C, and then incubated with biotinylated anti-rabbit IgG secondary antibody. A DAB substrate kit (Vector Laboratories, Burlingame, CA) was used to detect the immunohistochemical reaction.
Western blot analysis
Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes were blocked with 5% nonfat milk and incubated with specific primary antibodies overnight at 4°C. Antibodies against p-JNK, IRS-1, p-IRS-1, Akt, and p-Akt were purchased from Cell Signaling Technology (Beverly, MA), and antibodies against ALDH2 and caspase 3 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). An anti-AP-1 antibody was purchased from Abcam (Cambridge, MA). The membranes were incubated with horseradish peroxidase-coupled secondary antibodies. The membranes were developed using ECL Prime reagents (GE Healthcare, Piscataway, NJ) and chemiluminescence was detected using a LAS-4000 luminescent image analyzer (Fujifilm, Stamford, CT, USA). Densitometry analysis was performed using ImageJ software (National Institutes of Health, Bethesda, MA).
Real-time PCR
The TRIzol reagent (Invitrogen) was used to extract total RNA. Total RNA concentration was determined using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). First strand cDNA synthesis was performed using random primers and TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA). Real-time PCR was performed using predesigned TaqMan probe-primer sets and the Gene Expression Master Mix (Applied Biosystems) in a Prism 7500 system (Applied Biosystems), with the exception of DLL4, which was measured by the SYBR Green method using SsoFast EvaGreen Supermix (Bio-Rad Laboratories, Hercules, CA). The sequence of specific primers were as follows: collagen I: sense 5′-GTTCCTCCCAGCTCTCCATCAAGA-3′ and antisense 5′-GCTCTGGTCACAGGGTCTCATCTC-3′; collagen III: sense 5′-GGCTTCCTGCTCTTCCATCTCTTA-3′ and antisense 5′-CCTTCTCTAGGCGGCAAGTGACCT-3′; and transforming growth factor (TGF)-β1: sense 5′-TTGCTTCAGCTCCACAGAGA-3′ and antisense 5′-TGGTTGTAGAGGGCAAGGAC-3′. mRNA levels were normalized to β-actin. Relative mRNA expression was assessed using the 2 −∆∆Ct method.
Statistical analysis
Data are presented as the mean ± standard error of the mean (SEM). Comparisons were performed using one-way analysis of variance followed by a Tukey-Kramer post hoc test. P < 0.05 was considered statistically significant.
Results
ALDH2 improves the metabolic index of MS mice
Mice fed a HF diet had higher CHO, triglycerides, LDL-C, FBG, and FINS levels, and an elevated homeostatic model assessment of insulin resistance index compared with mice fed a normal diet ( Table 1 ). The mice in the HF diet group gained more weight than those in the normal diet group (Table 1) . After the injection of lentiviral vector, the mice in the ALDH2-
overexpression group exhibited the greatest decreases in these factors from baseline compared with the MS group. Furthermore, ALDH2 overexpression improved the metabolic index (Table 1) .
ALDH2 improves the e c h o c a r d i o g r a p h i c index in MS mice
The mice fed a HF diet exhibited significantly elevated LVEDD, LVESD, IVSd, and LVPWd and reduced EF and FS, and these effects were mitigated by ALDH2 overexpression. Additionally, compared with the MS mice, ALDH2 overexpression significantly slowed the progression of cardiac dysfunction ( Table  2) .
As expected, injection of the ALDH2-overexpression lentivirus significantly increased cardiac ALDH2 expression and ALDH2 enzymatic activity (Fig.  1A,B) . ALDH2 activity in cardiac mitochondria from mice with MS was markedly diminished compared with mice fed a normal diet (NC group) (Fig. 1B) . Interestingly, we observed a positive correlation between ALDH2 activity and EF (Fig. 1C) . 
ALDH2 attenuates MS-induced myocardial tissue damage
To assess the effects of ALDH2 overexpression on myocardial damage after chronic exposure to a HF diet, we examined heart morphology, collagen deposition, and cardiac ultrastructural changes. We observed a myocardial disorder in the MS mice, as evidenced by HE staining; this was attenuated in the ALDH2-overexpression group ( Fig. 2A-D) . Staining of cardiac sections with Masson's trichrome revealed increased interstitial collagen deposition after the induction of MS; however, interstitial collagen deposition was effectively prevented by ALDH2 overexpression (Fig. 2E-H, M) . Transmission electron microscopy ultrastructural analysis revealed swollen mitochondria in the cardiomyocytes from the MS mice compared to cardiomyocytes from the NC mice; these ultrastructural changes were effectively improved by ALDH2 overexpression (Fig. 2I-L) .
ALDH2 reduces MS-induced myocardial oxidative stress
To understand how ALDH2 overexpression attenuated myocardial damage, we examined myocardial oxidative stress. Myocardial ROS content and 4-HNE expression were significantly higher in the MS group than in the NC group (Fig. 3) . After lentiviral vector-mediated ALDH2 Cell (Fig. 3A-E) , and ROS content was reduced, though not to statistical significance (Fig.  3F) .
ALDH2 ameliorates MSinduced mitochondrial damage and apoptosis
Cardiomyocytes from mice in each group were examined for mitochondrial integrity and apoptosis. Abundant TUNEL-positive cells were observed in MS mice, but were significantly less frequent in the ALDH2-overexpression group (Fig.  4A-D) . In addition, we observed significant loss of mitochondrial membrane potential in cardiomyocytes from the MS mice; the loss of mitochondrial membrane potential was attenuated in cardiomyocytes from mice in the ALDH2-overexpression group (Fig.  4F) . (Fig. 5) .
ALDH2 regulates the expression of TGF-β1, collagen I and collagen III in cardiac tissue
To explore the possible mechanisms by which ALDH2 ameliorates MS-induced myocardial fibrosis, we examined the expression of TGF-β1 and collagen I and III in cardiac tissues. MS significantly upregulated the expression of collagen I and III and TGF-β1 in cardiac tissues; however, the downregulated expression of collagen I and III and TGF-β1 was observed in cardiac tissue from mice in the ALDH2-overexpression group (Fig. 6 ).
Discussion
In this study, we produced obesity and metabolic disturbances in mice fed a HF diet, which mimic human MS. Using this model, we demonstrated that MS caused significant myocardial lesions, increased myocardial apoptosis, and induced myocardial fibrosis. In addition, we revealed a cardioprotective role for ALDH2 against myocardial remodeling induced by a HF diet.
Our results demonstrated that lentiviral vector-mediated ALDH2 overexpression ameliorated myocardial damage induced by a HF diet, possibly by reducing oxidative stress and improving insulin resistance. Additionally, our study indicated crosstalk between JNK and AP-1 signaling pathways, converging on p-IRS-1 and leading to the inhibition of Akt phosphorylation and cell apoptosis. Another convergence point of the JNK and AP-1 pathways was TGF-β1 pathway, which promotes myocardial fibrosis in MS mice induced by a HF diet.
The hallmarks of lipotoxic cardiomyopathy include reduced contractility and deposition of lipid droplets in cardiomyocytes [21, 22] . We observed reduced EF and FS, enlarged LVEDD and LVESD, elevated IVSd and LVPWd, and excessive apoptosis, deposition of lipid droplets, and collagen fibers in cardiomyocytes of MS mice. Several mechanisms may be responsible for these MS-related abnormalities, including impaired insulin resistance and increased oxidative stress [23, 24] . In this study, impaired insulin resistance may underscore the accelerated apoptosis and myocardial fibrosis in cardiac tissue of MS mice induced by a HF diet. ALDH2 overexpression ameliorated HF diet-induced myocardial damage, consistent with previous findings that mitochondrial protection is beneficial against myocardial dysfunction induced by a HF diet [25, 26] . We observed increased apoptosis and loss of [27] . Although ALDH2 overexpression alleviated aortic plaque development in apoE-/-mice [28] , the effect of ALDH2 on lipotoxicity in the hearts of animals with MS is poorly understood. In this study we found that ALDH2 overexpression ameliorated HF diet-induced cardiac remodeling and contractile dysfunction, accompanied by improved mitochondrial integrity and myocyte survival. We suggest that the protective effect of ALDH2 is due to inhibition of JNK/AP-1 pathway. In the heart, both JNK and AP-1 are key regulators of myocardial remodeling [11, 29] . In addition, hypertension-induced cardiac dysfunction is associated with increased AP-1 activity [5] . In this study, we found that enhanced JNK phosphorylation and decreased Akt phosphorylation were associated with impaired cardiac function in response to the chronic consumption of a HF diet. JNK and Akt are essential for energy metabolism, cardiac survival, and contractile function [30, 31] . Our observation that ALDH2 inhibits JNK phosphorylation and compensates for the loss of Akt activation in response to a HF diet represents a possible connection between these pathways. The activation of AP-1 and JNK increases TGF-β1 expression and promotes myocardial fibrosis [32] . Therefore, JNK and AP-1 signaling may elicit apoptosis by reducing Akt phosphorylation, and may sensitize myocardial fibroblasts to pathophysiological changes.
In addition, the alteration of AP-1, which inhibits the transcription of α1 procollagen, is associated with increased collagen production [33] . Caspase 3 is a regulator of cell apoptosis and is involved in Akt-mediated anti-apoptotic mechanisms [34] . Our data demonstrate enhanced caspase 3 activity, mitochondrial damage, and myocardial fibrosis in MS mice but not in MS mice with ALDH2 overexpression. These data reveal a possible role for JNK and AP-1 in HF diet-induced mitochondrial dysfunction and cell apoptosis, and support a beneficial role for ALDH2. However, our data suggest an associative relationship between these signaling pathways, rather than a causal relationship; further study is needed to elucidate the functional role of AP-1, JNK, and Akt in mediating the cardioprotection provided by ALDH2.
In conclusion, this study reveals a crucial protective role for ALDH2 in the protection against HF diet-induced cardiac lipotoxicity. ALDH2 attenuates the cardiac dysfunction, apoptosis, oxidative stress and mitochondrial damage induced by a HF diet, possibly by inhibiting the activation of AP-1 and JNK and enhancing the phosphorylation of Akt. We conclude that ALDH2 is a potential therapeutic target that could be used in the management of MS.
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